Cargando…
Olanzapine-Induced Neuroleptic Malignant Syndrome
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening idiosyncratic side effect resulting from neuroleptic drugs. NMS mainly occurs in patients treated with high-potency typical antipsychotics, but rarely caused by atypical antipsychotics. Although NMS is less common with atypical anti...
Autores principales: | Hosseini, Seyedhamze, Elyasi, Forouzan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Journal of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429500/ https://www.ncbi.nlm.nih.gov/pubmed/28533580 |
Ejemplares similares
-
Olanzapine-induced Neuroleptic Malignant Syndrome
por: Saha, Pradeep Kumar, et al.
Publicado: (2017) -
Olanzapine induced neuroleptic malignant syndrome
por: Patra, Bichitra Nanda, et al.
Publicado: (2013) -
The management challenges of a case with Flupentixol‐induced neuroleptic malignant syndrome
por: Elyasi, Forouzan, et al.
Publicado: (2022) -
A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period
por: Üstündağ, Mehmet, et al.
Publicado: (2007) -
Neuroleptic malignant syndrome in a patient with stable dose of olanzapine
por: Sahoo, Manoj Kumar, et al.
Publicado: (2017)